Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co., Ltd. researches, develops, and manufactures anti-cancer drug products. Its pipeline includes antibody-based anticancer drugs such as the exosome anticancer drugs SOB101 and SOB102, SOB201 for engineered multi-target exosomes, SOA101, a dual immune checkpoint T cell adapter antibody, and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2011 and is based in Taichung, Taiwan.